Novo Nordisk A/S Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (48)

Latest Posts

About This Stock More About This Stock
E Taking A Long View
Article By: Vivian Lewis
Monday, April 9, 2018 9:28 AM EDT
China and Trump are both making big threats as a negotiating strategy. This will go on for months and we have to examine other parts of the stock market but other market news is worthy of analysis.
In this article: FLIP, NPSNY, TCEHY, INFY, SHPG, NVO, VALE, NILSY, CCJ, ORA, MXE, GLD, HSBC
Read
IBB – Challenging 2016, Recovering 2017 And Resurgence In 2018
Article By: Noah Kiedrowski
Tuesday, February 6, 2018 3:12 PM EDT
The Biotechnology cohort has finally notched a 52-week high and has made up much of the lost ground during the pummeling from both sides of the political isle during the 2016 presidential race.
In this article: AGN, JNJ, NVO, IBB, REGN, GILD, JUNO, ABBV, KITE
Read
E Sh-tdown To End
Article By: Vivian Lewis
Monday, January 22, 2018 12:15 PM EDT
News today from Bermuda, Brazil, Britain, Canada, Chile, China, Colombia, Denmark, Dutch Antilles, France, Finland, Germany, India, Ireland, Israel, Italy, Japan, Mexico, Panama, Sweden, Switzerland, and the USA where the sh-tdown is being ended.
In this article: AIG, CEA, SLFPY, NTR, BLX, BP, EONGY, SLB, EC, DGRLY, AGU, CB, CZZ, SQM, VR, XYL, PPEHF, SNY, TEVA, NVO, SHPG, MZOR, SANM, NOK, TCEHY, SAN, TCTZF, DCM, MXE, CTY Also: AMZN
Read
3 Large-Cap Pharma Stocks To Watch Out For This New Year
Article By: Zacks Investment Research
Friday, January 5, 2018 4:35 AM EDT
The year 2017 has turned out to be pretty impressive for the pharma/biotech stocks.
In this article: NVO, RHHBY, ABBV Also: AMGN
Read
4 Large-Cap Pharma Stocks That Outperformed The S&P This Year
Article By: Zacks Investment Research
Sunday, December 31, 2017 2:53 PM EDT
Upbeat quarterly results, rise in demand on new product sales, successful innovation and product line expansion, strong clinical study results as well as strong performance of legacy products propelled the large-cap drug sector to new highs in 2017.
In this article: AZN, JNJ, NVO, ABBV Also: RHHBY
Read

PARTNER HEADLINES

Latest Tweets for $NVO

No tweets yet!